deferoxamine has been researched along with thalidomide in 6 studies
Timeframe | Studies, this research(%) | All Research% |
---|---|---|
pre-1990 | 2 (33.33) | 18.7374 |
1990's | 0 (0.00) | 18.2507 |
2000's | 1 (16.67) | 29.6817 |
2010's | 3 (50.00) | 24.3611 |
2020's | 0 (0.00) | 2.80 |
Authors | Studies |
---|---|
Barnes, JC; Bradley, P; Day, NC; Fourches, D; Reed, JZ; Tropsha, A | 1 |
Chen, M; Hu, C; Suzuki, A; Thakkar, S; Tong, W; Yu, K | 1 |
Faigle, JW; Fritz, H; Keberle, H; Loustalot, P; Schmid, K | 1 |
Hunger, A; Keberle, H; Misra, AL | 1 |
Cosler, LE; Ferro, SA; Greenberg, PL; Lyman, GH | 1 |
Altés, A; De Paz, R; del Cañizo, C; López Arrieta, JM | 1 |
1 review(s) available for deferoxamine and thalidomide
Article | Year |
---|---|
DILIrank: the largest reference drug list ranked by the risk for developing drug-induced liver injury in humans.
Topics: Chemical and Drug Induced Liver Injury; Databases, Factual; Drug Labeling; Humans; Pharmaceutical Preparations; Risk | 2016 |
5 other study(ies) available for deferoxamine and thalidomide
Article | Year |
---|---|
Cheminformatics analysis of assertions mined from literature that describe drug-induced liver injury in different species.
Topics: Animals; Chemical and Drug Induced Liver Injury; Cluster Analysis; Databases, Factual; Humans; MEDLINE; Mice; Models, Chemical; Molecular Conformation; Quantitative Structure-Activity Relationship | 2010 |
[On the penetration of foreign body materials into the young vertebrate embryo].
Topics: Animals; Deferoxamine; Embryo Implantation; Embryo, Mammalian; Female; Glycosaminoglycans; Lipids; Pregnancy; Rabbits; Thalidomide; Tolbutamide | 1966 |
The passage of drugs across the rat intestine in vitro.
Topics: Angiotensin II; Animals; Carbon Isotopes; Deferoxamine; Female; Glutethimide; In Vitro Techniques; Intestinal Absorption; Intestinal Mucosa; Male; Permeability; Rats; Serous Membrane; Thalidomide | 1966 |
The costs of drugs used to treat myelodysplastic syndromes following National Comprehensive Cancer Network Guidelines.
Topics: Anemia; Antineoplastic Agents; Azacitidine; Cost of Illness; Costs and Cost Analysis; Darbepoetin alfa; Decision Support Techniques; Deferoxamine; Drug Costs; Drug Therapy; Epoetin Alfa; Erythropoietin; Hematinics; Humans; Iron Chelating Agents; Lenalidomide; Myelodysplastic Syndromes; Practice Guidelines as Topic; Recombinant Proteins; Siderophores; Thalidomide; United States | 2008 |
[Myelodysplastic syndrome in the elderly: comprehensive geriatric assessment and therapeutic recommendations].
Topics: Aged; Aged, 80 and over; Antineoplastic Agents; Blood Transfusion; Decision Support Techniques; Deferoxamine; Erythropoietin; Health Status Indicators; Humans; Lenalidomide; Myelodysplastic Syndromes; Prognosis; Siderophores; Thalidomide | 2012 |